UAE approves use of drug to combat 'silent killer' high cholesterol

The UAE has recently approved the use of Lipfendra, a daily pill developed by Merck, to combat high cholesterol, a condition that puts millions at risk of heart disease and strokes. The drug, which reduces levels of low-density lipoprotein (LDL) cholesterol, known as "bad cholesterol," was authorized by the US Food and Drug Administration (FDA) last month.

It marks the second country in the world to approve the medication, following its initial approval in the US. The Emirates Drug Establishment (EDE) stated that the drug would be prescribed to adult patients as part of a treatment plan determined by a healthcare professional, alongside a balanced diet and exercise. Lipfendra was found to reduce LDL cholesterol by up to 59 percent after 24 weeks of use in clinical trials.

Cholesterol, a waxy substance found in the blood, is essential for the body to build healthy cells, but high levels can increase the risk of heart disease and other health conditions. High cholesterol is often caused by poor lifestyle choices, such as lack of exercise, an unhealthy diet, and consuming large amounts of saturated fat.

It is also hereditary. The UAE's approval of Lipfendra comes as part of a drive to improve patient outcomes and expand treatment options.

Brief written by urgent.news from The National UAE's own syndicated text. Machine-written — may contain errors; check the original before relying on it.